Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current Assets:    
Cash and cash equivalents $ 36,456 $ 50,612
Restricted cash 13,069 11,513
Accounts receivable, net of allowance for credit losses of $105 and $378, respectively 68,655 86,888
Inventories 66,628 54,373
Derivative instruments 4,973 15,839
Other current assets 9,340 10,301
Total current assets 199,121 229,526
Property and equipment, net 239,069 222,550
Other Assets:    
Right of use operating lease assets, net 18,937 13,413
Notes receivable, noncurrent 11,641
Intangible assets, net 9,087 2,678
Goodwill 5,970
Other assets 6,137 5,145
Total other assets 40,131 32,877
Total Assets 478,321 484,953
Current Liabilities:    
Accounts payable – trade 28,115 23,251
Accrued liabilities 26,556 21,307
Current portion – operating leases 3,849 3,909
Derivative instruments 6,732 13,582
Other current liabilities 12,765 7,553
Total current liabilities 78,017 69,602
Long-term debt, net 68,356 50,361
Operating leases, net of current portion 15,062 9,382
Other liabilities 8,797 10,394
Total Liabilities 170,232 139,739
Commitments and contingencies (Notes 1, 9, 10, 11 and 16)
Stockholders’ Equity:    
Preferred stock, value
Common stock, value 75 73
Additional paid-in capital 1,040,834 1,037,205
Accumulated other comprehensive income (loss) 1,822 (284)
Accumulated deficit (734,643) (691,781)
Total stockholders’ equity 308,089 345,214
Total Liabilities and Stockholders’ Equity 478,321 484,953
Series A Preferred Stock    
Stockholders’ Equity:    
Preferred stock, value
Series B Preferred Stock    
Stockholders’ Equity:    
Preferred stock, value 1 1
Non-voting common stock    
Stockholders’ Equity:    
Common stock, value